These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8165567

  • 1. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo.
    Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P.
    Symp Soc Exp Biol; 1993; 47():227-34. PubMed ID: 8165567
    [Abstract] [Full Text] [Related]

  • 2. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM.
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 4. The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis.
    Rosen EM, Zitnik RJ, Elias JA, Bhargava MM, Wines J, Goldberg ID.
    EXS; 1993 Dec 01; 65():301-10. PubMed ID: 7678533
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W, Rook SL, Jiang ZY, Takahara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 2000 Jun 01; 41(7):1885-93. PubMed ID: 10845613
    [Abstract] [Full Text] [Related]

  • 6. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P.
    Lab Invest; 1997 Apr 01; 76(4):565-77. PubMed ID: 9111517
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.
    Gherardi E, Sharpe M, Lane K, Sirulnik A, Stoker M.
    Symp Soc Exp Biol; 1993 Apr 01; 47():163-81. PubMed ID: 8165564
    [Abstract] [Full Text] [Related]

  • 8. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.
    Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T, Mansel RE.
    Clin Cancer Res; 1999 Nov 01; 5(11):3695-703. PubMed ID: 10589789
    [Abstract] [Full Text] [Related]

  • 9. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Nov 01; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R, Soriano JV, Malinda KM, Ponce ML, Bafico A, Kleinman HK, Bottaro DP, Aaronson SA.
    Cell Growth Differ; 1998 May 01; 9(5):355-65. PubMed ID: 9607557
    [Abstract] [Full Text] [Related]

  • 11. Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.
    Kuba K, Matsumoto K, Ohnishi K, Shiratsuchi T, Tanaka M, Nakamura T.
    Biochem Biophys Res Commun; 2000 Dec 29; 279(3):846-52. PubMed ID: 11162438
    [Abstract] [Full Text] [Related]

  • 12. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS, Weijer K, van den Berk PC, Muller EJ, Miranda N, Bakker AQ, Heemskerk MH, Hekman A, de Gast GC, Gerritsen WR.
    Br J Cancer; 1999 Sep 29; 81(1):43-53. PubMed ID: 10487611
    [Abstract] [Full Text] [Related]

  • 13. Evidence of human thrombomodulin domain as a novel angiogenic factor.
    Shi CS, Shi GY, Chang YS, Han HS, Kuo CH, Liu C, Huang HC, Chang YJ, Chen PS, Wu HL.
    Circulation; 2005 Apr 05; 111(13):1627-36. PubMed ID: 15795324
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R.
    Cancer Res; 2006 Mar 01; 66(5):2673-82. PubMed ID: 16510587
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug 01; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 16. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T.
    Cancer Res; 2000 Dec 01; 60(23):6737-43. PubMed ID: 11118060
    [Abstract] [Full Text] [Related]

  • 17. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH.
    Hepatology; 2002 Nov 01; 36(5):1089-97. PubMed ID: 12395318
    [Abstract] [Full Text] [Related]

  • 19. Scatter factor and hepatocyte growth factor: activities, properties, and mechanism.
    Bhargava M, Joseph A, Knesel J, Halaban R, Li Y, Pang S, Goldberg I, Setter E, Donovan MA, Zarnegar R.
    Cell Growth Differ; 1992 Jan 01; 3(1):11-20. PubMed ID: 1534687
    [Abstract] [Full Text] [Related]

  • 20. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 01; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.